Astrogliosis due to brain injury or disease can lead to varying molecular and morphological changes in astrocytes. Magnetic resonance elastography and ultrasound have demonstrated that brain stiffness varies with age and disease state. However, there is a lack in understanding the role of varied stiffness on the progression of astrogliosis highlighting a critical need to engineer in vitro models that mimic disease stages. Such models need to incorporate the dynamic changes in the brain microenvironment including the stiffness changes. In this study we developed a polydimethyl siloxane (PDMS) based platform that modeled the physiologically relevant stiffness of brain in both a healthy (200 Pa) and diseased (8000 Pa) state to investigate the effect of stiffness on astrocyte function. We observed that astrocytes grown on soft substrates displayed a consistently more quiescent phenotype while those on stiff substrates displayed an astrogliosis-like morphology. In addition to morphological changes, astrocytes cultured on stiff substrates demonstrated significant increase in other astrogliosis hallmarks -cellular proliferation and glial fibrillary acidic protein (GFAP) protein expression. Furthermore, culturing astrocytes on a stiff surface resulted in increased reactive oxygen species (ROS) production, increased super oxide dismutase activity and decreased glutamate uptake. Our platform lends itself for study of potential therapeutic strategies for brain injury focusing on the intricate brain microenvironment-astrocytes signaling pathways.
Introduction
The brain is a mechanically heterogeneous organ that utilizes endogenous mechanical forces to regulate aspects of the tissue and cellular function. Magnetic resonance elastography, ultrasound and mechanical compression techniques have demonstrated that stiffness of brain regions vary 1,2 and these mechanical properties substantially change with age and disease state. [3] [4] [5] [6] [7] Although endogenous micromechanical energy is important for normal brain function, substantially greater mechanical forces acting on the brain can result in loss of consciousness, irreversible cognitive dysfunction, progressive neurodegeneration and even death. [8] [9] [10] Numerous studies have focused on the deleterious consequences of brain injury and disease, however, the host of deleterious molecular signaling pathways triggered as cellular-mechanical consequences of head trauma and the underlying mechanisms of these injuries are still not clear. Several studies have demonstrated that the mechanical microenvironment of a cell inuences key aspects of cell functionality and structure. [11] [12] [13] [14] [15] [16] Hence, it is critical to investigate the role of varied stiffness on cellular function.
The classically accepted paradigm regards neurons as the major player associated with brain function in normal and diseased states. Astrocytes -the most abundant cell type in the brain -have largely been considered as supporting cells for neurons that provide an ideal environment for neuronal-cell function but have no direct role in brain activity. However, accumulating evidence has challenged this paradigm to suggest that astrocytes are sophisticated participants in a diverse variety of functions for normal brain development and activity.
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Studies have also implicated astrocytes to play an important role in the progression of several neurodegenerative diseases, including, Alzheimer's disease (AD), Parkinson' disease, Down syndrome, Amyotrophic lateral sclerosis and epilepsy. [22] [23] [24] [25] [26] Astrogliosis/reactive astrocytosis is marked by an abnormal increase in the number of astrocytes frequently observed in brain trauma, infection, stroke, and neurodegenerative diseases. 27 This process involves activation of astrocytes leading to production of proinammatory mediators such as cytokines, chemokines, glutamate, reactive oxygen species (ROS), and prostanoids. 28, 29 During astrogliosis, astrocytes become hypertrophic with up-regulated expression of intermediate laments (e.g. glial brillary acidic protein (GFAP), vimentin), oxidative stress markers, and cytokines. Advanced astrogliosis ultimately leads to formation of glial scar as a physical barrier, which can inhibit axonal regeneration. 30 Reactive astrocytosis is not merely a marker for neuropathology, but plays an essential role in orchestrating injury response, regulating inammation and overall tissue repair that markedly impacts functional and clinical outcomes. While there has been reasonable progress toward understanding astrocyte physiology, little is known about the effect of changes in brain microenvironment, including stiffness, in mediating astrogliosis.
In our study, we utilized a polydimethyl siloxane (PDMS) based substrate with tunable stiffness to study the effect of various degrees of stiffness on the phenotype of primary rat cortical astrocytes. Our working hypothesis is that variation in matrix stiffness will inuence astrocyte phenotype and function, and that astrocytes will subsequently develop astrogliosislike responses to mechanical perturbation. We employed a so substrate (200 Pa) to represent healthy brain tissue and stiff substrate (8000 Pa) to represent diseased brain tissue as these fall in the range of previous in vivo and in vitro investigations into brain stiffness and the effect of changing brain stiffness. 2, 3, [31] [32] [33] We studied the effect of stiffness on commonly accepted hallmarks of astrogliosis including changes in cell morphology, proliferation, expression of vimentin and GFAP. Further we characterized the effect of stiffness on glutamate uptake, an important function of astrocytes, and perturbation of cellular oxidative state induced by the surface stiffness. Our observations indicate a strong dependence of primary astrocytes function on the culture substrate stiffness thus demonstrating a potential pathway for the progression of astrogliosis.
Materials and methods

Substrate characterization
CytoSo® 6-well plates of stiffness measured to be elastic modulus 200 Pa and 8000 Pa were purchased from Advanced BioMatrix. Extensive property testing was performed by Advanced BioMatrix to assure the quality of surfaces. Surfaces were coated with poly-L-lysine (PLL) prior to cell seeding according to manufacturer instructions. Florescent images of carboxyuorescein treated PLL surfaces (N ¼ 3) were imaged and the uorescence intensity quantied by Image J Analysis Soware [NIH] to demonstrate the uniformity of substrate coating is not varied by substrate stiffness.
Isolation and culture of primary astrocytes
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. 
ROS generation
5-(and-
is a uorescent indicator activated by the presence of ROS. The intensity of CM-H 2 DCFDA was quantied using a FACS Cantoll (BD). Culture media was aspirated and the cells washed with warm PBS. 10 mM CM-H 2 DCFDA [Life Technologies] in DMEM was added to each well and incubated at 37 C for 30 min. Cells were washed three times with PBS, trypsinized, transferred to DMEM in ow cytometry tubes and analyzed for uorescence in the green channel (ex. 495, em. 520; 100 000 total events/read) against cells not treated with CM-H 2 DCFDA.
Superoxide dismutase activity
The activity of CuZnSOD was measured by in gel reduction of nitroblue tetrazolium method described in Natarajan et al. with some modications. 38 First, proteins were lysed in a buffer consisting of 50 mM NaCl, 5 mM EDTA, 0.1% Triton X-100 and protease inhibitor. Next the protein was quantied by BCA assay and samples containing 30 mg protein made with loading dye consisting of 25 mM Tris-HCl (6.8), 50% glycerol, 0.5% bromophenol blue. A 12% bis-acrylamide gel without SDS was utilized with a running buffer consisting of 0.2 M glycine, 0.02 M Trizma and 0.01 M EDTA. Aer samples were separated by gel electrophoresis the gel was removed and incubated for 30 
Gene expression
Total RNA expression was quantied by quantitative real time PCR as described previously. utilizing the DDCT method. Final results were reported as normalized to the average relative expression on the so surface.
Statistical analysis
All data is presented as the mean AE the standard deviation. Statistical comparisons between treatments utilized sigma plot Student T-test and pool size as indicated. For data, which did not follow a Gaussian distribution, a Mann-Whitney rank test was employed with pool size as indicated.
Results
Stiffness induces astrogliotic morphology and actin stress bers
To determine if altering the physical stress experienced on the cellular level could induce an astrogliosis-like morphology, we isolated primary astrocytes and cultured the cells on PLL coated PDMS substrates of varied stiffness (Fig. 1) . with more process extensions and increased surface area. To assure that this observed phenomena was not a result of heterogeneous PLL coating, we measured the uorescent intensity of adsorbed carboxyuorescein on PLL coated so and stiff surfaces and found surface coating uniformity on both substrates (ESI Fig. 1 †) . We further investigated the effect of stiffness on cell morphology by immunostaining the actin cytoskeletal structure ( Fig. 2A) . Similar to the phase images, astrocytes on 200 Pa substrates had a rounded morphology with smaller cell bodies while the morphology substantially changed when cultured on 8000 Pa substrates possessing larger cell bodies and stretched morphology. Quantication revealed the average cell size on the stiff surface covered 1.6 (P < 0.05) times the surface area of the average cell cultured on the so surface (Fig. 2B) . Furthermore cells on the so surface had a circularity rank of 0.43 while cells Fig. 1 Schematic of experimental design. Primary rat astrocytes were isolated from day 1-3 rat pups. Culture purity was determined to be >90% GFAP positive cells by immunocytochemistry. Cells were seeded on PLL coated Cytosoft® 6 well plates with physiologically relevant stiffness (200 Pa per soft mimics healthy brain tissue and 8000 Pa per stiff mimics diseased/injured brain tissue). After three days in culture, the phenotypic markers and changes in morphology of primary astrocytes were assessed to demonstrate astrogliosis like behavior in astrocytes when cultured on stiff substrates. Scale bar 100 mm. (Fig. 2C) . This observation is similar to other studies that have demonstrated astrocytes were less branched, more rounded and had quiescent morphology on surfaces between 100 and 300 Pa while astrocytes had more branching, covering more surface area on surfaces greater than 1000 Pa. 33, 40, 41 We also observed a dramatic increase in actin organization and cell polarizability on stiffer (8000 Pa) surfaces. This has been observed in other cells and is generally known as actomyosin bundles or stress bers.
42-44
Stiffness increases astrocytes proliferation
Studies have demonstrated that astrogliosis results in the increase of astrocytes present in damaged areas by induction of astrocyte proliferation. 27 We investigated the effect of stiffness on astrocytes proliferation on so (200 Pa) and stiff (8000 Pa) substrates using BrdU staining (Fig. 3A) . We observed that astrocytes on stiff substrates had a 1.7 fold increase (P < 0.05) in BrdU staining compared to those on so substrates aer 72 hours in culture. In our study we utilized BrdU assay and ow cytometry to quantify the phenotypic change independent of cell number. BrdU assay measured the incorporation of BrdU in replicating DNA early in mitotic cell cycle due to proliferation and ow cytometry allowed for the quantication on a per cell basis evaluating the average orescent intensity of 10 000 cells. Therefore our data demonstrated that the changes in brain stiffness might be one of the potential causes for the increase in astrocytes during brain injury.
Stiffness induces up-regulation of GFAP expression
We next investigated the effect of stiffness on GFAP protein expression, an intermediate lament expressed exclusively by astrocytes. Increase in GFAP protein expression is a clinical hallmark sign of astrogliosis both in vivo and in vitro.
27,45 A 1.3 fold up-regulation (P < 0.05) in GFAP protein expression (Fig. 3B) was observed in astrocytes cultured on stiff substrates (8000 Pa) compared to so substrates (200 Pa). Further, we probed the effect of stiffness on the protein expression of a less recognized intermediate gliolament, vimentin, which has also been observed to increase in astrogliosis and found no up-regulation in protein expression (Fig. 3B ) in primary astrocytes cultured on stiff substrates compared to so substrates. As gene expression proceeds protein expression, and can be used as an early indication of phenotypic change, to further probe the vimentin expression RT-PCR was utilized to quantify gene expression.
46-48
It was observed that vimentin gene expression (ESI Fig. 2 †) was up-regulated 1.6 fold (P < 0.05) indicating a temporally sensitive effect of substrate stiffness on vimentin expression. Although increase in GFAP and vimentin expression have been extensively used as astrogliosis markers in vivo and in vitro, studies in vimentin knock-out mice have shown that vimentin upregulation is not required for induction of astrogliosis. 49 This observation, in combination with the previous results, supports 
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Stiffness increases ROS production and SOD activity in primary astrocytes
Animals and other experimental models have demonstrated that specic signaling cascades including production and release of toxic levels of ROS might stimulate astrogliosis. 50-52 Utilizing H 2 DCFDA and ow cytometry we quantied the effect of stiffness on generation of intercellular levels of ROS when primary astrocytes were cultured in either a healthy or a stiff diseased-like environment (Fig. 4A) . A 9-fold increase (P < 0.001) in intercellular ROS production was observed in astrocytes cultured on stiff substrates compared to so substrates. This is a signicant nding as animal studies have demonstrated that chronic neuorinammation and neurodegeneration associated with massive/ prolong brain injury or astrocyte stress leads to amplication of a microglia-astrocyte crosstalk and uncontrolled release of ROS.
50-52 Our model demonstrates that primary astrocytes cultured on stiffer substrate experience increase in ROS levels similar to the transition observed in the animal injury models.
The uncontrolled increase in ROS can lead to oxidative stress and cellular damage if not countered by the activity of endogenous anti-oxidant species as has been seen in a number of toxicology and neurodegenerative disease studies.
38,53,54
Copper-zinc super oxide dismutase (CuZnSOD) is an endogenous anti-oxidant which targets the reduction of super oxide species into peroxide to alleviate oxygen radicals and protect the cell from oxidative stress. 55 The CuZnSOD activity was measured (Fig. 4B) utilizing an in gel NBT reduction assay and found to be increased by 1.5 fold (P < 0.05) in astrocytes cultured on the 8000 Pa surface compared to the astrocytes on 200 Pa PDMS. These result demonstrate the ability of this model to follow the adaptive oxidative state pathways of reactive astrocytes which could increase understanding of the astrogliotic phenotype and uncover potential therapeutic methods.
Stiffness induces loss in glutamate uptake in primary astrocytes
Glutamate uptake is a paramount function of astrocytes in proper brain activity. Consequently, we investigated the effect of stiffness induced astrogliosis phenotype on the regulation 
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View Article Online of the glutamate uptake mechanism in astrocytes (Fig. 5) . We rst quantied the overall functionality of glutamate transport and observed a 2-fold decrease (P < 0.05) in glutamate uptake in primary astrocytes cultured on stiff substrates compared to those on so. To elicit the cause of glutamate uptake loss, we next quantied the gene and protein expression of key glutamate transporters in relation to substrate stiffness. Five subtypes of glutamate transporters have been identied in rodents and humans including glutamate/asparate transporter (GLAST) and glutamate transporter 1 (GLT1) as the transporters predominately expressed in astrocytes and required for regulating the glutamate uptake in the brain.
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Therefore, we quantied the relative GLAST and GLT1 gene expression following culture on so and stiff surfaces as changes in gene expression may be an early indication of transporter protein alteration. Although GLAST expression remained similar on the varied surfaces, GLT1 expression was signicantly increased (1.4 fold, P < 0.05) on the 8000 Pa surface (Fig. 5B) . Furthermore, we quantied GLT1 and GLAST protein expression to indicate if the change in gene expression was followed similarly to the change in protein expression. The quantication of protein expression indicated no change in GLT1 or GLAST protein expression (Fig. 5C ) conrming that the alteration in glutamate uptake was not a result of altered transporter expression resulting from culture surface stiffness. This data is useful to provide insight to the current pool of understanding on glutamate homeostasis and variation in tissue stiffness.
Discussion
Astrogliosis/reactive astrocytes are a prominent and ubiquitous reaction of astrocytes to many forms of brain injury, oen implicated in the poor regenerative capacity of the central nervous system (CNS). Reactive astrogliosis is associated with new gene expression or up-regulation of molecules that are at low levels in quiescent astrocytes. 27, 57, 58 However, little is known about the structural and molecular mechanisms underlying the transformation of astrocytes to the reactive state. Furthermore, there are currently no comprehensive proles of brain injuryinitiated protein changes in reactive astrocytes.
Animal models such as stab wound-induced brain injury, neurotoxic lesions, genetic diseases (twitcher mouse) and inammatory demyelination (experimental allergic encephalomyelitis) have been extensively used to investigate the progression of astrogliosis. 59 However, in vivo models have numerous drawbacks including: (1) the challenge associated with mechanistic study of reactive astrogliosis induction, (2) difficulties in reproducing the same extent of injuries in multiple experiments, (3) interference of systemic response to trauma in specic cellular effect and (4) inability to identify biochemical properties of reactive astrocytes.
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In vitro models allow the investigation of an isolated phenomenon in a well-dened environment, which is free from complex cellular interactions. Established astrogliosis in vitro models include in vitro mechanical injury model (e.g. scratch wound, platform stretch), 61,62 low temperature trauma model, and addition of growth factors to astrocyte cultures.
64,65
However, these methods result in heterogeneous population of injured and uninjured cells resulting in varying gene and protein expression changes in astrocytes. Furthermore, these models do not facilitate the understanding of the molecular and cellular properties of astrocytes resulting from extended, static mechanical change in brain microenvironment, such as that resulting from swelling or change in microenvironment composition, and how they regulate the functional astrocytes. There is a critical need for an in vitro injury model to be able to investigate the molecular changes in astrocytes systematically and quantitatively in a reproducible manner. In this study we utilized a PDMS based platform to investigate the effect of stiffness on primary astrocyte function. This approach has several advantages over the previously mentioned methods including ease of replication, uniformity of injury and ability to mimic mechanical properties of brain microenvironment in different disease states. PDMS is a biocompatible, stable and tunable material which provides a platform with uniform mechanical properties. The uniform mechanical properties induces a homogeneous population of "injured" cells which can be assessed for molecular changes resulting from mechanical stiffness. PDMS is chemically inert but can be uniformly modied with PLL, a standard culture dish coating for neural cells, to facilitate astrocyte attachment. This allows for a uniform chemical coating which assures that change in cellular phenotype is solely the result of platform mechanical stiffness.
We employed a so substrate (200 Pa) to represent healthy brain tissue and stiff substrate (8000 Pa) to represent diseased brain tissue. These values were chosen due to the following reasoning: (1) the elastic modulus of healthy rat and porcine brain has been measured via indentation techniques and found to fall in the range of 100 to 400 Pa, 31, 66 and (2) it has been suggested that the changes in local mechanical properties may play a role in disease pathology, thus we utilized a PDMS platform of greater stiffness (8000 Pa) to determine if altering the physical forces on the cellular level solely prompts the onset of astrogliosis. Although tissue maturity and some neurodegenerative diseases have been shown to decrease the overall tissue stiffness several injury and disease states, such as metastatic tumor, stroke and traumatic brain injury, have been observed to signicantly increase tissue stiffness. 3, 4, 7, [67] [68] [69] The successful induction of astrogliotic phenotype by this model serves to provide preliminary information on the phenotypic changes of astrocytes due to local alteration of microenvironmental stiffness in vitro. We observed that astrocytes grown on so substrates displayed a consistently more quiescent phenotype while those on stiff substrates displayed astrogliosis-like phenotype. Georges and coworkers demonstrated that neurons have consistent actomysin formation regardless of surface stiffness while astrocytes demonstrated mechanosensitivity by increased polarization on stiff surfaces.
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Prager-Khoutorsky and coworkers demonstrated that human broblasts also showed similar changes in morphology possessing smaller, rounded morphology in so substrates and elongated morphology with large focal adhesion points in stiff substrates. 70 Overall our data supports the hypothesis that reactive morphology is induced by increased surface stiffness.
Primary astrocytes cultured on stiff substrates demonstrated signicant increase in common hallmarks for astrogliosisglial brillary acidic protein (GFAP) protein expression and proliferation. Previous studies have shown that astrocytes devoid of GFAP expression are unable to accomplish the reactive phenotype in injury and disease. 45, 71 This is the rst stiffness induced astrogliosis model to quantify a cellular increase in GFAP protein expression although stretch, hyperthermia and chemically induced models of astrogliosis have all observed similar up-regulation post injury. 62, 63, 72 Previous models have utilized GFAP staining to identify astrocyte populations and quantify cell numbers on so and stiff polyacrylamide (PA) gels but have not quantied protein expression. These studies utilized GFAP staining to indicate an increased presence of astrocytes on stiff surfaces attributing this to difficulty of astrocytes to attach and grow on so polyacrylamide (PA) gels.
33, 73 Georges et al. quantied the difference in adhesion by counting the number of cells attached to so (200 Pa) and stiff (9000 Pa) surfaces at 4 and 24 h of culture. They noted a slightly higher number of astrocytes at 4 h compared to 24 h suggesting a time dependent cell detachment from the so surfaces not observed on stiff surfaces. 33 Furthermore, Jiang and coworkers quantied the number of mature astrocytes attached to so (300 Pa) vs. stiff (27 and 230 kPa) PA gels by counting GFAP positive astrocytes and found a signicantly higher number of adherent astrocytes on stiff PA gels. 73 Our results suggest that an increase in astrocyte number in our model on stiff surfaces is dependent on induction of proliferation by the per cell analysis of BrdU incorporation in astrocyte DNA. Our observations support the hypothesis that the increase in culture surface stiffness induces a reactive phenotype in astrocytes.
Our study observed that astrocytes on stiff disease-like surface also resulted in increased ROS production and antioxidant CuZnSOD activity. This is akin to the observation in animal studies that have demonstrated chronic neuorinammation and neurodegeneration associated with massive/ prolong brain injury or astrocyte stress leading to uncontrolled release of ROS. [50] [51] [52] Further, superoxide dismutase (SOD) is an anti-oxidative species in eukaryotic cells which convert superoxide radicals into hydrogen peroxide to prevent oxidative stress and damage in the presence of increased ROS generation. The most important parameter determining biological impact of SOD is the enzyme anti-oxidant activity with copper-zinc SOD (CuZnSOD) constituting approximate 90% of all SOD activity in eukaryotic cells. 55 Our results show that reactive astrocytes induced by mechanical stiffness experience an increase in ROS generation and increase in CuZnSOD activity suggesting that the oxidative state of reactive astrocytes is changed from those of quiescent astrocytes as they adapt to the increased stress from varied microenvironment. To our knowledge, no study has specically investigated and demonstrated a role of stiffness in regulation of ROS levels in astrocytes. Since varied oxidative state is a commonly observed mechanism in disease these results indicate our platform lends itself for investigation of potential therapeutic strategies manipulating oxidative state during brain injury focusing on the intricate brain microenvironment-astrocytes signaling pathways.
Previtera and coworkers demonstrated that the global glutamate concentration of mixed cultures do not change between so and stiff surfaces when the ratio of neurons to astrocytes were similar however when the ratio of neurons was higher than that of astrocytes the global concentration of glutamate increased suggesting that the number of astrocytes is key to the global concentration of glutamate. 74 Jiang and coworkers showed that neurons in mixed cultures were much less susceptible to excitotoxicity on stiffer gels. 73 This resistance is attributed to an increased number of astrocytes on the stiff environment compared to soer substrates. Our results are in agreement with these studies and provide insight that increased number of astrocytes may be needed to prevent glutamate toxicity as the capacity of individual astrocytes to uptake glutamate is decreased on stiff surfaces. Furthermore, to probe why there is an observed loss in glutamate uptake we quantied the gene expression of glutamate transporters. Our results observed no change in GLAST expression and a signicant increase in GLT1 gene expression on the stiff surface suggesting that the loss in function is not a result of decreased gene expression. Furthermore, GLAST and GLT1 protein expression was unchanged on the 8000 Pa surface compared to the 200 Pa surface. This indicates that the loss in glutamate uptake is unrelated to the amount of glutamate transporters expressed and therefore must lie in some other mechanism. To uncover the root of glutamate homeostasis perturbation it would be benecial to observe other factors inuencing transporter function, energy metabolism and mitochondrial health. This may be an informative future work of mechanistic discovery utilizing this platform but is beyond the scope of the current work. In the current study, we have demonstrated the potential of our in vitro platform to emulate the onset of astrogliosis by modeling the stiffness of brain in healthy and injury state. Our platform recreates astrogliosis in vitro by inducing cellular adaptation to increasing microenvironment stiffness. This model can be used to facilitate understanding the role of complex cell-microenvironment interactions that are hard to dissect in clinical conditions of brain injury and neurodegenerative diseases.
In summary (Fig. 6) , we demonstrated an innovative approach to model astrogliosis on tunable substrates that recreate the varying stiffness in brain mimicking healthy and diseased state. This approach has several advantages over the method used by other group including high delity, ease of duplication, biocompatibility and ability to mimic brain microenvironment in different disease states. We have provided evidence that our platform emulates the various clinical markers of astrogliosis by modulating the stiffness of the substrate to correlate with normal (200 Pa) and injury (8000 Pa) conditions of brain microenvironment. To validate the mimicry of the clinical conditions, we observed that astrocytes grown on the healthy brain stiffness (200 Pa) displayed a consistently more quiescent morphology as compared to astrocytes cultured on stiff substrate (8000 Pa) that displayed reactive morphology. Furthermore, we also demonstrated that our model captured the changes in proliferation and GFAP protein expression, clinical hallmarks for astrogliosis. We demonstrated that astrocytes cultured on stiffer environment resulted in increased ROS levels, CuZnSOD activity and loss in glutamate uptake, thus compromising functional aspects of astrocytes. This platform provides a robust system to compare the temporal changes of astrocytes in the clinical markers and functional aspects of the cells at the molecular level. Our model can be utilized to investigate the intricate brain microenvironment-astrocytes signaling pathways and possibly lend to identifying new therapeutic strategies for brain injury. 
